RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Precision BioSciences Stock

Precision BioSciences Employees 2024

Precision BioSciences Employees

225

Ticker

DTIL

ISIN

US74019P1084

WKN

A2PGA1

In 2024, Precision BioSciences employed 225 people, a 0% change from the 225 number of employees in the previous year.

Precision BioSciences Aktienanalyse

What does Precision BioSciences do?

Precision BioSciences was founded in 2006 in Durham, North Carolina, USA and is a biotech company specializing in the development of genome editing technologies. The company's main products are genomic single-strand cutter (GSSC) enzymes and related solutions that provide advanced ways to edit genomes. Precision BioSciences focuses on creating innovative technologies and partnerships with industrial, scientific, and academic partners. Through the development of new products and expanding its business relationships, Precision BioSciences has built a strong market presence in recent years. Precision BioSciences has two business divisions: Genome Editing and Food. The Genome Editing division is dedicated to developing new technologies for modifying genes in living cells. A key product of this division is ARCUS, a patented gene editing toolkit. ARCUS consists of two main components, a GSSC enzyme and a specific DNA target, and provides detailed, precise, and controlled editing of genomes. The technology offers a high level of flexibility, efficiency, and precision. The Food division focuses on the development of plants in agriculture and serves as an important complement to the Genome Editing division. Precision BioSciences uses advanced technologies like ARCUS to edit the genomics of plants and improve their traits, such as resistance to pests or heat. The company works closely with scientific partners and the agricultural industry to develop innovative solutions for the requirements of modern farming. Precision BioSciences has introduced a range of impressive products that meet the growing demand for genome editing. Some notable products include: CAR T-cell therapy: A revolutionary cancer treatment that uses inactivated virus and ARCUS technology to achieve outstanding results in the treatment of leukemias and lymphomas. Advanced papaya: This technology utilizes ARCUS to produce papayas that have resistance to papaya virus disease. This innovative solution aims to increase crop yields and reduce crop loss. PrecisionXtract: A new service that processes patient data to ensure precise and effective genome editing. This product is designed to meet the requirements of clinical studies and medical procedures while ensuring safety and sustainability. Overall, Precision BioSciences has established its position in the genome editing market thanks to its innovative product line, strong partnerships, and comprehensive knowledge and expertise. With a solid footing in the genome editing market, Precision BioSciences is well-positioned to continue expanding and developing innovative solutions for the genomics of humans, animals, and plants. Precision BioSciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Precision BioSciences's Employee Base

Precision BioSciences's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Precision BioSciences's operational capacity and future potential.

Year-to-Year Comparison

Assessing Precision BioSciences's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Precision BioSciences's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Precision BioSciences’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Precision BioSciences stock

How many employees does Precision BioSciences have this year?

Precision BioSciences has 225 undefined employees this year.

How many employees did Precision BioSciences have compared to the previous year?

Compared to the previous year, Precision BioSciences had 0% more employees.

What impact did the number of employees have on the company Precision BioSciences?

The number of employees has a direct impact on the efficiency and productivity of Precision BioSciences. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Precision BioSciences?

The number of employees can also have an impact on investors of Precision BioSciences, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Precision BioSciences affect the company?

An increase in equity of Precision BioSciences can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Precision BioSciences's equity affect the company?

A reduction in equity of Precision BioSciences can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Precision BioSciences?

Some factors that can influence the equity of Precision BioSciences include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Precision BioSciences so important for investors?

The equity of Precision BioSciences is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Precision BioSciences influence the company?

The number of employees at Precision BioSciences can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Precision BioSciences evolved in recent years?

In recent years, the number of employees at Precision BioSciences has changed by 0.

How many employees does Precision BioSciences currently have?

Precision BioSciences currently has 225 undefined employees.

Why is the number of employees important for investors of Precision BioSciences?

The number of employees is important for investors of Precision BioSciences as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Precision BioSciences take to change the number of employees?

To change the number of employees, Precision BioSciences can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Precision BioSciences pay?

Over the past 12 months, Precision BioSciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Precision BioSciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Precision BioSciences?

The current dividend yield of Precision BioSciences is .

When does Precision BioSciences pay dividends?

Precision BioSciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Precision BioSciences?

Precision BioSciences paid dividends every year for the past 0 years.

What is the dividend of Precision BioSciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Precision BioSciences located?

Precision BioSciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Precision BioSciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Precision BioSciences from 11/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.

When did Precision BioSciences pay the last dividend?

The last dividend was paid out on 11/4/2024.

What was the dividend of Precision BioSciences in the year 2023?

In the year 2023, Precision BioSciences distributed 0 USD as dividends.

In which currency does Precision BioSciences pay out the dividend?

The dividends of Precision BioSciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Precision BioSciences stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Precision BioSciences

Our stock analysis for Precision BioSciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Precision BioSciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.